Endocannabinoid system: A new player in the percutaneous and surgical treatment of coronary artery disease?
- PMID: 32861715
- DOI: 10.1016/j.ijcard.2020.08.075
Endocannabinoid system: A new player in the percutaneous and surgical treatment of coronary artery disease?
Conflict of interest statement
Declaration of Competing Interest None.
Comment on
-
The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair.Int J Cardiol. 2021 Jan 15;323:243-250. doi: 10.1016/j.ijcard.2020.08.042. Epub 2020 Aug 15. Int J Cardiol. 2021. PMID: 32810540
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
